Cavendish is pleased to announce that it has advised on the sale of EIDO Healthcare to leading provider of digital risk management and quality compliance software, Radar Healthcare.

EIDO is a a trusted specialist in patient information and informed consent, EIDO Healthcare partners with healthcare organisations globally, including over 65% of NHS hospitals in the UK, to provide modular solutions to support informed consent, enhance patient outcomes, and reduce clinical risks.

Together, EIDO and Radar, as two established providers of healthcare solutions, will combine their expertise to deliver best-in-class tools for organisations across the health and care landscape, supporting safer and more effective care. By uniting Radar Healthcare’s innovative technology and EIDO’s trusted informed consent solutions, the combined organisation is poised to accelerate growth and enhance its offering for customers in the health and care markets across the globe. This news follows a significant investment in Radar Healthcare last year from Marlin Equity Partners.

Anthony Platt, Partner and Head of Technology at Cavendish commented:

“This transaction underscores Cavendish’s growing presence in the health tech sector and brings together the complementary strengths of both EIDO and Radar, especially following the significant investment from Marlin Equity Partners last year, that sets them apart from the industry.

EIDO’s commitment to empowering clinicians with accurate and patient-centred solutions is integral to addressing critical challenges in healthcare delivery and the partnership with Radar represents a crucial step forward.

We are excited to see how Radar leverage EIDO’s expertise to drive meaningful results for both patients and healthcare providers alike.”